... CEO in December 2010. "He'll do anything to get the stock price up," said Jeff Jonas, an investor with Gabelli & Co. in Rye, New York. "As long as he continues to have that view, he'll be fine." AstraZeneca yesterday rejected New York-based Pfizer's ...
http://ift.tt/1lJ5wjE
http://ift.tt/1lJ5wjE
No comments:
Post a Comment